tradingkey.logo
tradingkey.logo

Bioversys Expects Total Operating Loss Of CHF 40-45 Mln For FY2026

ReutersMar 18, 2026 7:40 AM

- BioVersys AG BIOV.S:

  • BIOVERSYS REPORTS CORPORATE HIGHLIGHTS AND FINANCIAL RESULTS FOR THE FULL YEAR 2025

  • BIOVERSYS AG - EXPECTS TOTAL OPERATING LOSS OF CHF 40-45 MILLION FOR FY2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI